MUNDIPHARMA MEDICAL COMPANY LIMITED
Operating as part of the Sackler family-owned multinational Mundipharma group, the company is engaged in the wholesale distribution of pharmaceutical goods from its base at the Cambridge Science Park.
Get an alert when MUNDIPHARMA MEDICAL COMPANY LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£270m
+170.6% highest in 3 filed years
Net assets
£462m
-23.3% vs 2024
Employees
107
-6.1% lowest in 3 filed years
Profit before tax
-£179m
-343.7% lowest in 3 filed years
Net assets
3-year trend · vs Consumer Discretionary median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £337,928,000 | £287,148,000 | £354,423,000 | +23.4% | |
| Operating profit | £49,835,000 | £71,255,000 | -£51,779,000 | -172.7% | |
| Profit before tax | £51,914,000 | £73,521,000 | -£179,139,000 | -343.7% | |
| Net profit | £38,721,000 | £54,417,000 | -£139,996,000 | -357.3% | |
| Cash | £74,694,000 | £99,716,000 | £269,850,000 | +170.6% | |
| Total assets less current liabilities | £98,133,000 | £641,707,000 | £777,911,000 | +21.2% | |
| Net assets | £58,133,000 | £601,707,000 | £461,711,000 | -23.3% | |
| Equity | £58,133,000 | £601,707,000 | £461,711,000 | -23.3% | |
| Average employees | 123 | 114 | 107 | -6.1% | |
| Wages | £12,161,000 | £13,521,000 | £12,940,000 | -4.3% | |
| Directors' remuneration | £0 | £0 | £0 | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Operating margin | 14.7% | 24.8% | -14.6% | |
| Net margin | 11.5% | 19.0% | -39.5% | |
| Return on capital employed | 50.8% | 11.1% | -6.7% | |
| Gearing (liabilities / total assets) | 82.2% | 28.9% | 55.2% | |
| Current ratio | 1.17x | 2.87x | 3.15x | |
| Interest cover | — | 28.50x | -4.66x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Ernst & Young LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Company continues to generate cash on an ongoing basis. Accordingly, the directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for a period of 18 months to 31st January 2028 and, thus, they continue to adopt the going concern”
Group structure
- MUNDIPHARMA MEDICAL COMPANY LIMITED · parent
- Mundipharma Biologics SL (formerly Cinfa Biotech SL) 100%
- Mundipharma International Services S.a.r.l. 100%
- Mundipharma International Services GmbH 100%
- Mundipharma EDO GmbH 100%
- Mundipharma International Services Limited 100%
- MN Consulting LLC 100%
- Mundipharma Ophthalmology Products Limited 100%
- Mundipharma Regulatory Limited (dormant) 100%
Significant events
- “In March 2026, there was an early repayment of the loan payable to Napp Pharmaceuticals Ltd of £4,595,873.”
- “In May 2026, a payment has been made in regard to the exceptional settlement cost of £111m.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 7 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| JAMIESON, Stephen Johan | Director | 2019-02-22 | Sep 1957 | British |
| LEA, Bryan George | Director | 2015-08-25 | Jun 1961 | British |
Show 7 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BAKER, Stuart David | Director | 2014-10-21 | 2019-12-31 |
| KUDLEK, Birgit, Dr | Director | 2020-01-01 | 2020-10-31 |
| MARTINEZ, Alberto | Director | 2016-10-11 | 2019-10-01 |
| MATTESSICH, Antony Charles | Director | 2015-08-25 | 2017-07-31 |
| SHIELS, Sara Elizabeth | Director | 2015-08-25 | 2018-01-07 |
| SILVER, David Alan | Director | 2015-08-25 | 2019-05-03 |
| WIKSTROM, Ake Gunnar | Director | 2018-04-12 | 2019-02-22 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mr Jeffrey Robins | Individual | Significant influence (as trust) | 2018-11-20 | Active |
| Mrs Alexa Mairi Saunders | Individual | Significant influence (as trust) | 2018-03-05 | Active |
| Mr Peter Minton Ward | Individual | Shares 25–50% (as trust) | 2016-04-06 | Ceased 2018-06-03 |
| Mr Christopher Benbow Mitchell | Individual | Shares 25–50% (as trust) | 2016-04-06 | Ceased 2018-04-12 |
| Mr Leslie John Schreyer | Individual | Significant influence (as trust) | 2016-04-06 | Active |
| Mrs Hermance Bernadette Monique Schaepman | Individual | Shares 25–50% (as trust) | 2016-04-06 | Active |
Filing timeline
Last 20 of 78 total filings
Material constitutional events — rename, articles re-file, resolution
- 2025-05-28 RESOLUTIONS Resolution
- 2025-05-28 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-09-15 | AA | accounts | Accounts with accounts type full | |
| 2026-06-25 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2026-06-18 | PSC04 | persons-with-significant-control | Change to a person with significant control | |
| 2025-11-17 | CH01 | officers | Change person director company with change date | |
| 2025-11-04 | AA | accounts | Accounts with accounts type full | |
| 2025-06-13 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-05-28 | RESOLUTIONS | resolution | Resolution | |
| 2025-05-28 | RESOLUTIONS | resolution | Resolution | |
| 2025-05-23 | SH01 | capital | Capital allotment shares | |
| 2025-05-01 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2025-02-06 | AD02 | address | Change sail address company with old address new address | |
| 2025-02-05 | AD01 | address | Change registered office address company with date old address new address | |
| 2024-08-29 | AA | accounts | Accounts with accounts type full | |
| 2024-06-19 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-04-04 | CH01 | officers | Change person director company with change date | |
| 2023-10-02 | AA | accounts | Accounts with accounts type group | |
| 2023-06-17 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-06-12 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-04-22 | AA | accounts | Accounts with accounts type group | |
| 2022-07-04 | CH01 | officers | Change person director company with change date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 5
- Capital events
- 1
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.